Product Information
METHAZOLAMIDE 50 MG TABLET is a generic product labeled by Oceanside Pharmaceuticals, priced at $1.5082 per EA under NDC 68682002310. Its NADAC has been published 249 times since Dec 30, 2020.
FDA first approved this application on Oct 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the methazolamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682002310
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
METHAZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207438FDA Approved
10/5/2018
TE Code
AB
On Market Since
10/2/2020
Price Statistics
The NADAC for METHAZOLAMIDE 50 MG TABLET has been published 249 times since Dec 30, 2020, and over the history we have for it it has declined 63.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5082 per EA |
|---|---|
| All-time high | $5.5114 (Aug 11, 2021) |
| All-time low | $1.3336 (May 22, 2024) |
| Median price | $2.3784 |
| Average price | $2.7417 |
| Largest weekly change | +58.4% (Aug 17, 2022) |
| Weeks tracked | 249 |
| Tracking since | Dec 30, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-41.7%
5Y
-67.2%
All
-63.0%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methazolamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHAZOLAMIDE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHAZOLAMIDE 50 MG TABLET, manufactured by Oceanside Pharmaceuticals, is $1.5082 per EA (NDC 68682002310), effective Oct 1, 2025.
How has the price of METHAZOLAMIDE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHAZOLAMIDE 50 MG TABLET has declined 63.0%. It has been tracked across 249 weekly CMS publications since Dec 30, 2020.
What are the highest and lowest recorded NADAC prices for METHAZOLAMIDE 50 MG TABLET?
Since Dec 30, 2020, the NADAC for METHAZOLAMIDE 50 MG TABLET has ranged from a low of $1.3336 (May 22, 2024) to a high of $5.5114 (Aug 11, 2021), with a median of $2.3784 per EA.
Are there cheaper alternatives to METHAZOLAMIDE 50 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHAZOLAMIDE 50 MG TABLET, is $1.4684 per EA — about 3% below METHAZOLAMIDE 50 MG TABLET.
Who manufactures METHAZOLAMIDE 50 MG TABLET?
METHAZOLAMIDE 50 MG TABLET (NDC 68682002310) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.